Scholar : Acta Oncologica, Volume 56, Issue 4, April 2017 is now available online on Taylor & Francis Online

The online platform for Taylor & Francis Online content Acta Oncologica, Volume 56, Issue 4, April 2017 is now available online on Taylor & Francis Online. This new issue contains the following articles: EDITORIAL Longitudinal multi-parametric imaging in radiation oncology: boon or bane? Dirk de Ruysscher & Daniela Thorwarth Pages: 501-502 | DOI: 10.1080/0284186X.2017.1296583 REVIEW HIF-1 in cancer therapy: two decade long story of a transcription factor Sourabh Soni & Yogendra S. Padwad Pages: 503-515 | DOI: 10.1080/0284186X.2017.1301680 ORIGINAL ARTICLES: THORACIC ONCOLOGY Evolution of [18F]fluorodeoxyglucose and [18F]fluoroazomycin arabinoside PET uptake distributions in lung tumours during radiation therapy Dario Di Perri, John A. Lee, Anne Bol, François-Xavier Hanin, Guillaume Janssens, Daniel Labar, Annie Robert, Edmond Sterpin & Xavier Geets Pages: 516-524 | DOI: 10.1080/0284186X.2017.1287943 Systematic evaluation of lung tumor motion using four-dimensional computed tomography Sebastian Sarudis, Anna Karlsson Hauer, Jan Nyman & Anna Bäck Pages: 525-530 | DOI: 10.1080/0284186X.2016.1274049 A study of the beam-specific interplay effect in proton pencil beam scanning delivery in lung cancer Minglei Kang, Sheng Huang, Timothy D. Solberg, Rulon Mayer, Andy Thomas, Boon-Keng Kevin Teo, James E. McDonough, Charles B. Simone II & Liyong Lin Pages: 531-540 | DOI: 10.1080/0284186X.2017.1293287 Is there a different dose–effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study Lisa Van den Bosch, Gilles Defraene, Stéphanie Peeters, Christophe Dooms, Walter De Wever, Christophe Deroose & Dirk De Ruysscher Pages: 541-547 | DOI: 10.1080/0284186X.2017.1293288 Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapy | Hilâl Tekatli, Shyama U. Tetar, Timothy K. Nguyen, Andrew Warner, Wilko F. Verbakel, David A. Palma, Max Dahele, Stewart Gaede, Cornelis Haasbeek, Femke O. Spoelstra, Patricia F. de Haan, Ben J. Slotman & Suresh Senan Pages: 548-554 | DOI: 10.1080/0284186X.2017.1295166 ORIGINAL ARTICLES: PROSTATE CANCER Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel Consuelo Buttigliero, Chiara Pisano, Marcello Tucci, Francesca Vignani, Valentina Bertaglia, Davide Iaconis, Pamela Guglielmini, Gianmauro Numico, Giorgio V. Scagliotti & Massimo Di Maio Pages: 555-562 | DOI: 10.1080/0284186X.2016.1260772 Socioeconomic position and mortality among patients with prostate cancer: influence of mediating factors Signe Benzon Larsen, Klaus Brasso, Jane Christensen, Christoffer Johansen, Anne Tjønneland, Søren Friis, Peter Iversen & Susanne Oksbjerg Dalton Pages: 563-568 | DOI: 10.1080/0284186X.2016.1260771 The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy Julie Mareschal, Kerstin Weber, Pascale Rigoli, Edmund Biason, Laura Frambati, Carole Gotteland, Thomas Zilli, Claude Pichard & Raymond Miralbell Pages: 569-574 | DOI: 10.1080/0284186X.2016.1273545 Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams Tracy S. A. Underwood, Justin C. Voog, Maryam Moteabbed, Shikui Tang, Edward Soffen, Oren Cahlon, Hsiao-Ming Lu, Anthony L. Zietman, Jason A. Efstathiou & Harald Paganetti Pages: 575-581 | DOI: 10.1080/0284186X.2016.1275781 ORIGINAL ARTICLES: RENAL CELL CANCER Assessment of ethnic differences in sunitinib outcome between Caucasian and Asian patients with metastatic renal cell carcinoma: a meta-analysis | Xiaoyan Liu, Marta Fiocco, Jesse J. Swen & Henk-Jan Guchelaar Pages: 582-589 | DOI: 10.1080/0284186X.2016.1265666 ORIGINAL ARTICLES: HAEMATOLOGICAL MALIGNANCIES Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation Mette Seland, Knut B. Smeland, Trine Bjøro, Ragnhild S. Falk, Sophie D. Fosså, Clara G. Gjesdal, Kristin Godang, Harald Holte, Johan Svartberg, Unni Syversen, Jens Bollerslev & Cecilie E. Kiserud Pages: 590-598 | DOI: 10.1080/0284186X.2016.1267870 Population-based experience on primary central nervous system lymphoma 2000–2012: the incidence is increasing Gunilla Enblad, Gustaf Martinsson, Eva Baecklund, Göran Hesselager, Christer Sundström, Rosie-Marie Amini & Hans Hagberg Pages: 599-607 | DOI: 10.1080/0284186X.2016.1270465 Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group Marianne C. Aznar, Theodore Girinsky, Anne Kiil Berthelsen, Berthe Aleman, Max Beijert, Martin Hutchings, Yolande Lievens, Paul Meijnders, Peter Meidahl Petersen, Deborah Schut, Maja V. Maraldo, Richard van der Maazen & Lena Specht Pages: 608-613 | DOI: 10.1080/0284186X.2017.1279750 ORIGINAL ARTICLES: BREAST CANCER Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen Johan Rosell, Bo Nordenskjöld, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per-Olof Malmström, Arne Wallgren, Olle Stål & John Carstensen Pages: 614-617 | DOI: 10.1080/0284186X.2016.1273547 Self-reported physical activity behavior of breast cancer survivors during and after adjuvant therapy: 12 months follow-up of two randomized exercise intervention trials Martina E. Schmidt, Joachim Wiskemann, Cornelia M. Ulrich, Andreas Schneeweiss & Karen Steindorf Pages: 618-627 | DOI: 10.1080/0284186X.2016.1275776 Publish your research with us! Growth Factors (Impact Factor: 2.043) is now inviting submissions. To update which email alerts you receive, manage your alerts within the My Account area. You can also unsubscribe from this alert with one click. If you need any further help, please contact us at support@tandfonline.com Please do not reply to this email. To ensure that you receive your alerts and information from Taylor & Francis Online, please add "alerts@tandfonline.com" and "info@tandfonline.com" to your safe senders list. Taylor & Francis, an Informa business. Taylor & Francis is a trading name of Informa UK Limited, registered in England under no. 1072954. Registered office: 5 Howick Place, London, SW1P 1WG.